Immune compartmentalization of T cell subsets in chemically-induced breast cancer

Scandinavian Journal of Immunology

Volumn 72, Issue 4, 2010, Pages 339-348

  Fahmi, T ^a   Esendagli, G ^a   Yilmaz, G ^b   Kansu, E ^a   Guc, D ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; FOXP3 PROTEIN, RAT; INTERLEUKIN 10; METHYLNITROSOUREA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; CHEMICALLY INDUCED; CYTOTOXIC T LYMPHOCYTE; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPH NODE; METABOLISM; NATURAL KILLER T CELL; PATHOLOGY; RAT; REGULATORY T LYMPHOCYTE; SPLEEN; SPRAGUE DAWLEY RAT; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; UDDER;

ANIMALS; ANTIGENS, CD3; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERLEUKIN-10; LYMPH NODES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; NATURAL KILLER T-CELLS; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956325993     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02447.x     Document Type: Article

References (43)

1. Selber JC, Nelson JA, Ashana AO et al. Breast cancer screening prior to cosmetic breast surgery: ASPS members' Adherence to American Cancer Society Guidelines. Plast Reconstr Surg 2009 124 : 1375 1385.
2. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006 6 : 715 727.
3. Yaqub S, Henjum K, Mahic M et al. Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner. Cancer Immunol Immunother 2008 57 : 813 821.
4. Peggs KS, Segal NH, Allison JP. Targeting immunosupportive cancer therapies: accentuate the positive, eliminate the negative. Cancer Cell 2007 12 : 192 199.
5. Nizar S, Copier J, Meyer B et al. T-regulatory cell modulation: the future of cancer immunotherapy? Br J Cancer 2009 100 : 1697 1703.
6. + regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 2007 21 : 2512 2518.
7. Alvaro T, Lejeune M, Salvado MT et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005 11 : 1467 1473.
8. Carreras J, Lopez-Guillermo A, Fox BC et al. High numbers of tumor-infiltrating Foxp3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006 108 : 2957 2964.
9. Qin FX. Dynamic behavior and function of Foxp3 + regulatory T cells in tumor bearing host. Cell Mol Immunol 2009 6 : 3 13.
10. Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a "sentinel node" in cancer of the parotid. Cancer 1960 13 : 77 8.
11. Sheu BC, Kuo WH, Chen RJ, Huang SC, Chang KJ, Chow SN. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. Breast 2008 17 : 604 610.
12. Macchetti AH, Marana HR, Silva JS, de Andrade JM, Ribeiro-Silva A, Bighetti S. Tumor-infiltrating CD4 + T lymphocytes in early breast cancer reflect lymph node involvement. Clinics (Sao Paulo) 2006 61 : 203 208.
13. Thompson HJ, Singh M. Rat models of premalignant breast disease. J Mammary Gland Biol Neoplasia 2000 5 : 409 420.
14. Isaacs JT. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 1986 46 : 3958 3963.
15. Hill M, Bausero M, Mazal D et al. Immunobiological characterization of N -nitrosomethylurea-induced rat breast carcinomas: tumoral IL-10 expression as a possible immune escape mechanism. Breast Cancer Res Treat 2004 84 : 107 116.
16. Esendagli G, Yilmaz G, Canpinar H, Gunel-Ozcan A, Guc MO, Guc D. Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea- induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats. Lab Anim 2009 43 : 60 4.
17. Esendagli G, Canpinar H, Yilmaz G et al. Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene. Cancer Biol Ther 2009 8 : 136 142.
18. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002 420 : 860 867.
19. Esendagli G, Bruderek K, Goldmann T et al. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer. Lung Cancer 2008 59 : 32 40.
20. DeNardo DG, Coussens LM. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 2007 9 : 212.
21. Seidel HJ. Hematologic effects of a single dose of methylnitrosourea. Exp Hematol 1977 5 : 19 26.
22. Inoue T, Cronkite EP, Commerford SL, Carsten AL. Residual toxicity in hematopoietic cells following a single dose of methylnitrosourea. Leuk Res 1984 8 : 105 116.
23. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006 6 : 295 307.
24. Kawaida H, Kono K, Takahashi A et al. Distribution of CD4 + CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer. J Surg Res 2005 124 : 151 157.
25. Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2005 2 : e284.
26. Zhou G, Levitsky HI. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J Immunol 2007 178 : 2155 2162.
27. Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL. A unique subset of CD4 + CD25highFoxp3 + T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res 2007 13 : 4345 4354.
28. Reiss M, Barcellos-Hoff MH. Transforming growth factor-beta in breast cancer: a working hypothesis. Breast Cancer Res Treat 1997 45 : 81 95.
29. Yu P, Fu YX. Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 2006 86 : 231 245.
30. Clarke SR. The critical role of CD40/CD40L in the CD4-dependent generation of CD8 + T cell immunity. J Leukoc Biol 2000 67 : 607 614.
31. Jarnicki AG, Lysaght J, Todryk S, Mills KH. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4 + and CD8 + regulatory T cells. J Immunol 2006 177 : 896 904.
32. Niederkorn JY. Emerging concepts in CD8(+) T regulatory cells. Curr Opin Immunol 2008 20 : 327 331.
33. Mahic M, Henjum K, Yaqub S et al. Generation of highly suppressive adaptive CD8(+)CD25(+)Foxp3(+) regulatory T cells by continuous antigen stimulation. Eur J Immunol 2008 38 : 640 646.
34. Tamada K, Harada M, Abe K et al. Immunosuppressive activity of cloned natural killer (NK1.1 +) T cells established from murine tumor-infiltrating lymphocytes. J Immunol 1997 158 : 4846 4854.
35. Azuma T, Takahashi T, Kunisato A, Kitamura T, Hirai H. Human CD4 + CD25 + regulatory T cells suppress NKT cell functions. Cancer Res 2003 63 : 4516 4520.
36. Stewart TJ, Lutsiak ME, Abrams SI. Immune consequences of protracted host-tumor interactions in a transgenic mouse model of mammary carcinoma. Cancer Invest 2008 26 : 237 249.
37. Hiura T, Kagamu H, Miura S et al. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression. J Immunol 2005 175 : 5058 5066.
38. Villablanca EJ, Raccosta L, Zhou D et al. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat Med 2010 16 : 98 105.
39. Woo SU, Bae JW, Yang JH, Kim JH, Nam SJ, Shin YK. Overexpression of interleukin-10 in sentinel lymph node with breast cancer. Ann Surg Oncol 2007 14 : 3268 3273.
40. Noma K, Yamaguchi Y, Okita R, Matsuura K, Toge T. The spleen plays an immunosuppressive role in patients with gastric cancer: involvement of CD62L+ cells and TGF-beta. Anticancer Res 2005 25 : 643 649.
41. Abe F, Dafferner AJ, Donkor M et al. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice. Cancer Immunol Immunother 2010 59 : 47 62.
42. Melani C, Chiodoni C, Forni G, Colombo MP. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 2003 102 : 2138 2145.
43. Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Invest 2007 117 : 1167 1174.